Adjuvia Therapeutics Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$8M
- Investors
-
3
Adjuvia Therapeutics General Information
Description
Developer of blood-brain barrier penetrant nanoparticle therapies designed to treat mitochondrial dysfunction. The company's technology utilizes a proprietary oral nanoparticle formulation and a patented harvesting method, enabling the delivery of small molecules across the blood-brain barrier to target rare and chronic degenerative diseases.
Contact Information
Website
www.adjuvia.comCorporate Office
- 953 Indiana Street
- San Francisco, CA 94107
- United States
Corporate Office
- 953 Indiana Street
- San Francisco, CA 94107
- United States
Adjuvia Therapeutics Timeline
Adjuvia Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 29-Jul-2026 | $8M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 01-Aug-2024 | Completed | Generating Revenue |
Adjuvia Therapeutics Patents
Adjuvia Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024369666-A1 | Pharmaceutical composition and method of treating disease using a molecular complex assembled on astaxanthin core | Pending | 30-Oct-2023 | ||
| EP-4801528-A1 | Pharmaceutical composition and method of treating disease using a molecular complex assembled on astaxanthin core | Pending | 30-Oct-2023 | ||
| WO-2025096604-A1 | Pharmaceutical composition and method of treating disease using a molecular complex assembled on astaxanthin core | Inactive | 30-Oct-2023 | ||
| US-20180094209-A1 | Extraction of essential oils | Inactive | 15-Sep-2014 | ||
| US-10227557-B2 | Method and apparatus for producing astaxanthin | Active | 15-Sep-2014 | C12N1/12 |
Adjuvia Therapeutics Signals
Adjuvia Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| JLo Ventures | Venture Capital | Minority | ||
| Portfolia | Venture Capital | Minority | ||
| MBC BioLabs | Accelerator/Incubator |
Adjuvia Therapeutics FAQs
-
When was Adjuvia Therapeutics founded?
Adjuvia Therapeutics was founded in 2023.
-
Where is Adjuvia Therapeutics headquartered?
Adjuvia Therapeutics is headquartered in San Francisco, CA.
-
What is the size of Adjuvia Therapeutics?
Adjuvia Therapeutics has 7 total employees.
-
What industry is Adjuvia Therapeutics in?
Adjuvia Therapeutics’s primary industry is Drug Discovery.
-
Is Adjuvia Therapeutics a private or public company?
Adjuvia Therapeutics is a Private company.
-
What is Adjuvia Therapeutics’s current revenue?
The current revenue for Adjuvia Therapeutics is .
-
How much funding has Adjuvia Therapeutics raised over time?
Adjuvia Therapeutics has raised $8M.
-
Who are Adjuvia Therapeutics’s investors?
JLo Ventures, Portfolia, and MBC BioLabs have invested in Adjuvia Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process